Researcher
Guido Vanham
Affiliations
- Virology (Research unit)
Member
From1 Jan 1989 → 30 Jul 2019
Projects
1 - 10 of 19
- Machine learning framework for T-cell receptor repertoire-based viral diagnosticsFrom3 Nov 2020 → Today
- Evaluation of the role of immune checkpoint molecules in the natural killer cell-mediated anti-HIV responseFrom11 Apr 2019 → Today
- Development of a novel nanoparticle formulation for mRNA based therapeutic vaccination against HIVFrom11 Apr 2019 → Today
- Immuno Cytometry: Phenotyping immune cellular components, in the context of HBV, HIV and AD, by new, advanced technologiesFrom18 Jan 2018 → 17 Aug 2020
- Interventions towards a functional cure: detailed phenotyping of the HIV-specific polyfunctional CD8+ T cell responses of controllersFrom24 Jun 2016 → 12 Feb 2020
- Search for host genetic factors associated with neurological complications (HAM/TSP) in Peruvian HTLV-1 infected individualsFrom18 May 2016 → 27 Sep 2016
- Rationeel ontwerp van een therapeutisch vaccin tegen HIV-1 gebaseerd op een nieuwe formulering van nanopartikelFrom1 Jan 2016 → 31 Dec 2020
- Cell-associated HIV-RNA as a superior marker of treatment success or failureFrom29 Apr 2015 → 19 Sep 2019
- Therapeutic TriMix/Mrna BASED Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral TherapyFrom1 Dec 2013 → 31 Dec 2017
- Inductie van breed-potente Hiv-1 suppressieve immuun responsen door dendritische cellen opgeladen met gag mRNA.From1 Jan 2011 → 21 Mar 2019
Publications
81 - 90 of 206
- In vitro evaluation of viability, integrity and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides(2010)
Authors: Y Gali, O Delezay, J. Brouwers, N Addad, P. Augustijns, T Bourlet, H Hamzeh-Cognasse, Kevin Ariën, B Pozzetto, G Vanham
Pages: 5105-5114 - Transcriptome analysis of monocyte-HIV interactions(2010)
Authors: R. Van den Bergh, Eric Florence, E Vlieghe, T Boonefaes, J. Grooten, E Houthuys, TH Tran Thi, Y Gali, P. De Baetselier, G Vanham, et al.
Pages: 53 - Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization(2010)
Authors: MA Jenabian, H Saidi, C. Charpentier, H Bouhlal, D Schols, J Balzarini, TW Bell, Guido Vanham, L Bélec
Pages: 16 - Unravelling the antigenic landscape of the HIV-1 subtype A envelope of an individual with broad cross-neutralizing antibodies using phage display peptide libraries(2010)
Authors: T Dieltjens, B Willems, S Coppens, L Van Nieuwenhove, M. Humbert, U Dietrich, L Heyndrickx, G Vanham, W Janssens
Pages: 95-102 - Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients(2010)
Authors: M Talledo, G Lopez, JR Huyghe, K Verdonck, V. Adaui, E González, I Best, D. Clark, G Vanham, E. Gotuzzo, et al.
Pages: 460-466 - Role of dendritic cells in HIV-immunotherapy(2010)
Authors: Ellen Van Gulck, VF Van Tendeloo, ZN Berneman, G Vanham
Pages: 310-322 - Analysis of infectious virus clones from two HIV-1 superinfection cases suggests that the primary strains have lower fitness(2010)
Authors: AC van der Kuyl, K Kozaczynska, Kevin Ariën, Y Gali, VR Balazs, SJ Dekker, F Zorgdrager, G Vanham, B Berkhout, M Cornelissen
Pages: 60 - Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses(2010)
Authors: W De Haes, S. De Koker, C Pollard, D. Atkinson, E Vlieghe, J Hoste, J Rejman, S. De Smedt, J. Grooten, G Vanham, et al.
Pages: 1408-1416 - The role of KIR gene content and HLA-C group in susceptibility to HTLV-1-associated myelopathy / tropical spastic paraparesis in Peru(2010)
Authors: M Talledo, G Lopez, JR Huyghe, K Verdonck, E González, D. Clark, D Senitzer, G Vanham, E. Gotuzzo, G Van Camp, et al.
Pages: 804-808 - Inhibition of HIV-1 by non-nucleoside reverse transcriptase inhibitors via an induced fit mechanism-importance of slow dissociation and relaxation rates for antiviral efficacy(2010)
Authors: M Elinder, P Selhorst, G Vanham, B Oberg, L Vrang, UH Danielson
Pages: 1133-1140